Mettler-Toledo International Inc. (MTD)
USD 1100.01
(4.11%)
USD 1100.01
(4.11%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.5 Billion USD | 1.09% |
| 2022 | 3.46 Billion USD | 9.9% |
| 2021 | 3.15 Billion USD | 24.63% |
| 2020 | 2.53 Billion USD | 6.9% |
| 2019 | 2.36 Billion USD | 16.75% |
| 2018 | 2.02 Billion USD | 1.31% |
| 2017 | 2 Billion USD | 15.63% |
| 2016 | 1.73 Billion USD | 20.43% |
| 2015 | 1.43 Billion USD | 11.52% |
| 2014 | 1.28 Billion USD | 5.89% |
| 2013 | 1.21 Billion USD | -5.61% |
| 2012 | 1.29 Billion USD | -9.29% |
| 2011 | 1.42 Billion USD | -5.9% |
| 2010 | 1.51 Billion USD | 50.0% |
| 2009 | 1 Billion USD | -13.08% |
| 2008 | 1.15 Billion USD | 5.68% |
| 2007 | 1.09 Billion USD | 14.71% |
| 2006 | 956.22 Million USD | -5.4% |
| 2005 | 1.01 Billion USD | 33.14% |
| 2004 | 759.18 Million USD | 3.53% |
| 2003 | 733.28 Million USD | -8.46% |
| 2002 | 801 Million USD | -0.03% |
| 2001 | 801.22 Million USD | 13.05% |
| 2000 | 708.74 Million USD | -0.02% |
| 1999 | 708.9 Million USD | -7.02% |
| 1998 | 762.4 Million USD | 5.83% |
| 1997 | 720.4 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3.44 Billion USD | -1.82% |
| 2024 Q2 | 3.4 Billion USD | -1.16% |
| 2023 Q4 | 3.5 Billion USD | 3.27% |
| 2023 Q3 | 3.39 Billion USD | -1.89% |
| 2023 Q2 | 3.46 Billion USD | 0.75% |
| 2023 FY | 3.5 Billion USD | 1.09% |
| 2023 Q1 | 3.43 Billion USD | -0.96% |
| 2022 Q1 | 3.27 Billion USD | 3.68% |
| 2022 Q3 | 3.37 Billion USD | 1.44% |
| 2022 FY | 3.46 Billion USD | 9.9% |
| 2022 Q4 | 3.46 Billion USD | 2.67% |
| 2022 Q2 | 3.32 Billion USD | 1.76% |
| 2021 Q2 | 2.95 Billion USD | 4.45% |
| 2021 Q1 | 2.82 Billion USD | 11.61% |
| 2021 FY | 3.15 Billion USD | 24.63% |
| 2021 Q3 | 3.04 Billion USD | 3.27% |
| 2021 Q4 | 3.15 Billion USD | 3.52% |
| 2020 Q2 | 2.22 Billion USD | -13.56% |
| 2020 Q1 | 2.57 Billion USD | 8.9% |
| 2020 Q3 | 2.32 Billion USD | 4.21% |
| 2020 Q4 | 2.53 Billion USD | 8.97% |
| 2020 FY | 2.53 Billion USD | 6.9% |
| 2019 Q4 | 2.36 Billion USD | 7.78% |
| 2019 Q1 | 2.07 Billion USD | 2.28% |
| 2019 Q2 | 2.15 Billion USD | 3.94% |
| 2019 Q3 | 2.19 Billion USD | 1.89% |
| 2019 FY | 2.36 Billion USD | 16.75% |
| 2018 Q2 | 2.02 Billion USD | 3.82% |
| 2018 Q3 | 2.02 Billion USD | 0.01% |
| 2018 Q4 | 2.02 Billion USD | 0.13% |
| 2018 FY | 2.02 Billion USD | 1.31% |
| 2018 Q1 | 1.95 Billion USD | -2.57% |
| 2017 Q2 | 1.78 Billion USD | 1.25% |
| 2017 Q4 | 2 Billion USD | 0.92% |
| 2017 FY | 2 Billion USD | 15.63% |
| 2017 Q1 | 1.76 Billion USD | 1.85% |
| 2017 Q3 | 1.98 Billion USD | 11.1% |
| 2016 FY | 1.73 Billion USD | 20.43% |
| 2016 Q2 | 1.56 Billion USD | 5.22% |
| 2016 Q1 | 1.49 Billion USD | 3.75% |
| 2016 Q3 | 1.72 Billion USD | 9.6% |
| 2016 Q4 | 1.73 Billion USD | 0.66% |
| 2015 Q1 | 1.3 Billion USD | 1.55% |
| 2015 Q2 | 1.44 Billion USD | 10.17% |
| 2015 Q3 | 1.46 Billion USD | 1.7% |
| 2015 Q4 | 1.43 Billion USD | -1.99% |
| 2015 FY | 1.43 Billion USD | 11.52% |
| 2014 Q2 | 1.23 Billion USD | 2.0% |
| 2014 Q1 | 1.21 Billion USD | -0.51% |
| 2014 Q4 | 1.28 Billion USD | 2.46% |
| 2014 FY | 1.28 Billion USD | 5.89% |
| 2014 Q3 | 1.25 Billion USD | 1.85% |
| 2013 Q4 | 1.21 Billion USD | -6.06% |
| 2013 Q3 | 1.29 Billion USD | -1.96% |
| 2013 Q2 | 1.32 Billion USD | 4.09% |
| 2013 Q1 | 1.27 Billion USD | -1.53% |
| 2013 FY | 1.21 Billion USD | -5.61% |
| 2012 Q1 | 1.3 Billion USD | -8.15% |
| 2012 Q4 | 1.29 Billion USD | 2.14% |
| 2012 Q3 | 1.26 Billion USD | -1.37% |
| 2012 FY | 1.29 Billion USD | -9.29% |
| 2012 Q2 | 1.28 Billion USD | -1.98% |
| 2011 FY | 1.42 Billion USD | -5.9% |
| 2011 Q3 | 1.47 Billion USD | -1.79% |
| 2011 Q4 | 1.42 Billion USD | -3.64% |
| 2011 Q1 | 1.5 Billion USD | -0.11% |
| 2011 Q2 | 1.5 Billion USD | -0.46% |
| 2010 Q3 | 1.15 Billion USD | 12.0% |
| 2010 FY | 1.51 Billion USD | 50.0% |
| 2010 Q2 | 1.02 Billion USD | 2.49% |
| 2010 Q1 | 1 Billion USD | -0.4% |
| 2010 Q4 | 1.51 Billion USD | 31.2% |
| 2009 FY | 1 Billion USD | -13.08% |
| 2009 Q1 | 1.1 Billion USD | -5.01% |
| 2009 Q3 | 1.02 Billion USD | -3.47% |
| 2009 Q4 | 1 Billion USD | -2.1% |
| 2009 Q2 | 1.06 Billion USD | -3.16% |
| 2008 Q1 | 1.17 Billion USD | 7.51% |
| 2008 FY | 1.15 Billion USD | 5.68% |
| 2008 Q2 | 1.19 Billion USD | 1.74% |
| 2008 Q3 | 1.23 Billion USD | 2.78% |
| 2008 Q4 | 1.15 Billion USD | -5.99% |
| 2007 Q4 | 1.09 Billion USD | 7.16% |
| 2007 Q1 | 933.78 Million USD | -2.35% |
| 2007 FY | 1.09 Billion USD | 14.71% |
| 2007 Q2 | 966.69 Million USD | 3.52% |
| 2007 Q3 | 1.02 Billion USD | 5.89% |
| 2006 Q1 | 963.3 Million USD | -4.7% |
| 2006 Q4 | 956.22 Million USD | 2.15% |
| 2006 Q3 | 936.09 Million USD | -4.96% |
| 2006 Q2 | 984.91 Million USD | 2.24% |
| 2006 FY | 956.22 Million USD | -5.4% |
| 2005 FY | 1.01 Billion USD | 33.14% |
| 2005 Q4 | 1.01 Billion USD | 32.02% |
| 2005 Q3 | 765.6 Million USD | -1.82% |
| 2005 Q2 | 779.79 Million USD | 3.76% |
| 2005 Q1 | 751.52 Million USD | -1.01% |
| 2004 Q3 | 709.41 Million USD | 1.59% |
| 2004 FY | 759.18 Million USD | 3.53% |
| 2004 Q4 | 759.18 Million USD | 7.02% |
| 2004 Q1 | 721.74 Million USD | -1.57% |
| 2004 Q2 | 698.32 Million USD | -3.25% |
| 2003 Q1 | 788.49 Million USD | -1.56% |
| 2003 Q4 | 733.28 Million USD | -3.33% |
| 2003 Q3 | 758.53 Million USD | -2.84% |
| 2003 Q2 | 780.7 Million USD | -0.99% |
| 2003 FY | 733.28 Million USD | -8.46% |
| 2002 Q1 | 796.42 Million USD | -0.6% |
| 2002 FY | 801 Million USD | -0.03% |
| 2002 Q4 | 801 Million USD | 3.69% |
| 2002 Q3 | 772.49 Million USD | -4.3% |
| 2002 Q2 | 807.2 Million USD | 1.35% |
| 2001 Q3 | 671.76 Million USD | 2.77% |
| 2001 FY | 801.22 Million USD | 13.05% |
| 2001 Q4 | 801.22 Million USD | 19.27% |
| 2001 Q1 | 666.07 Million USD | -6.02% |
| 2001 Q2 | 653.66 Million USD | -1.86% |
| 2000 Q4 | 708.74 Million USD | 8.55% |
| 2000 FY | 708.74 Million USD | -0.02% |
| 2000 Q2 | 668.9 Million USD | -1.24% |
| 2000 Q1 | 677.28 Million USD | -4.46% |
| 2000 Q3 | 652.92 Million USD | -2.39% |
| 1999 Q4 | 708.9 Million USD | -0.94% |
| 1999 Q2 | 722.9 Million USD | 3.67% |
| 1999 Q3 | 715.6 Million USD | -1.01% |
| 1999 FY | 708.9 Million USD | -7.02% |
| 1999 Q1 | 697.3 Million USD | -8.54% |
| 1998 FY | 762.4 Million USD | 5.83% |
| 1998 Q4 | 762.4 Million USD | 6.21% |
| 1998 Q1 | 697.6 Million USD | -3.63% |
| 1998 Q2 | 681 Million USD | -2.38% |
| 1998 Q3 | 717.8 Million USD | 5.4% |
| 1997 Q4 | 723.9 Million USD | 0.0% |
| 1997 FY | 720.4 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Agilent Technologies, Inc. | 4.91 Billion USD | 28.721% |
| Charles River Laboratories International, Inc. | 4.53 Billion USD | 22.718% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | 53.899% |
| Danaher Corporation | 30.99 Billion USD | 88.691% |
| Enzo Biochem, Inc. | 29.65 Million USD | -11722.113% |
| IQVIA Holdings Inc. | 20.56 Billion USD | 82.957% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | 60.321% |
| Qiagen N.V. | 2.3 Billion USD | -51.922% |
| Revvity, Inc. | 5.69 Billion USD | 38.413% |
| Thermo Fisher Scientific Inc. | 51.88 Billion USD | 93.244% |
| Waters Corporation | 3.47 Billion USD | -0.834% |